Development of Pediatric Glioma Models for BRAF-targeted Therapy

被引：4
|
作者：
Lang, Shih-Shan
Sievert, Angela J.
Boucher, Katie L.
Madsen, Peter J.
Slaunwhite, Erin
Brewington, Danielle
Storm, Phillip B.
Resnick, Adam C.
机构：
来源：
NEUROSURGERY | 2012年 / 71卷 / 02期
关键词：
D O I：
10.1227/01.neu.0000417783.83750.a5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
193
引用
收藏
页码：E575 / E575
页数：1
相关论文
共 50 条
  • [31] AXL inhibition improves BRAF-targeted treatment in melanoma
    Nyakas, Marta
    Fleten, Karianne Giller
    Haugen, Mads Haugland
    Engedal, Nikolai
    Sveen, Christina
    Farstad, Inger Nina
    Florenes, Vivi Ann
    Prasmickaite, Lina
    Maelandsmo, Gunhild Mari
    Seip, Kotryna
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [32] Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
    Talebi, Ali
    Dehairs, Jonas
    Rambow, Florian
    Rogiers, Aljosja
    Nittner, David
    Derua, Rita
    Vanderhoydonc, Frank
    Duarte, Joao A. G.
    Bosisio, Francesca
    Van den Eynde, Kathleen
    Nys, Kris
    Perez, Monica Vara
    Agostinis, Patrizia
    Waelkens, Etienne
    Van den Oord, Joost
    Fendt, Sarah-Maria
    Marine, Jean-Christophe
    Swinnen, Johannes V.
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [33] UPFRONT MOLECULAR TARGETED THERAPY FOR THE TREATMENT OF BRAF-MUTANT PEDIATRIC HIGH-GRADE GLIOMA
    Rosenberg, Tom
    Yeo, Kee Kiat
    Mauguen, Audrey
    Alexandrescu, Sanda
    Prabhu, Sanjay P.
    Tsai, Jessica W.
    Malinowski, Seth
    Joshirao, Mrinal
    Parikh, Karishma
    Sait, Sameer Farouk
    Rosenblum, Marc K.
    Benhamida, Jamal K.
    Michaiel, George
    Tran, Hung N.
    Dahiya, Sonika
    Kachurak, Kara
    Friedman, Gregory K.
    Krystal, JulieI.
    Huang, Michael A.
    Margol, Ashley S.
    Wright, Karen D.
    Aguilera, Dolly
    MacDonald, Tobey J.
    Chi, Susan N.
    Karajannis, Matthias A.
    [J]. NEURO-ONCOLOGY, 2022, 24 : 68 - 68
  • [34] Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanoma
    Mason, Robert
    Dearden, Helen C.
    Nguyen, Bella
    Soon, Jennifer A.
    Smith, Jessica Louise
    Randhawa, Manreet
    Mant, Andrew
    Warburton, Lydai
    Lo, Serigne
    Meniawy, Tarek
    Guminski, Alexander
    Parente, Phillip
    Ali, Sayed
    Haydon, Andrew
    Long, Georgina V.
    Carlino, Matteo S.
    Millward, Michael
    Atkinson, Victoria G.
    Menzies, Alexander M.
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2020, 33 (02) : 358 - 365
  • [35] Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
    Ali Talebi
    Jonas Dehairs
    Florian Rambow
    Aljosja Rogiers
    David Nittner
    Rita Derua
    Frank Vanderhoydonc
    Joao A. G. Duarte
    Francesca Bosisio
    Kathleen Van den Eynde
    Kris Nys
    Mónica Vara Pérez
    Patrizia Agostinis
    Etienne Waelkens
    Joost Van den Oord
    Sarah-Maria Fendt
    Jean-Christophe Marine
    Johannes V. Swinnen
    [J]. Nature Communications, 9
  • [36] Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade glioma
    Rosenberg, Tom
    Yeo, Kee Kiat
    Mauguen, Audrey
    Alexandrescu, Sanda
    Prabhu, Sanjay P.
    Tsai, Jessica W.
    Malinowski, Seth
    Joshirao, Mrinal
    Parikh, Karishma
    Sait, Sameer Farouk
    Rosenblum, Marc K.
    Benhamida, Jamal K.
    Michaiel, George
    Tran, Hung N.
    Dahiya, Sonika
    Kachurak, Kara
    Friedman, Gregory K.
    Krystal, Julie, I
    Huang, Michael A.
    Margol, Ashley S.
    Wright, Karen D.
    Aguilera, Dolly
    MacDonald, Tobey J.
    Chi, Susan N.
    Karajannis, Matthias A.
    [J]. NEURO-ONCOLOGY, 2022, 24 (11) : 1964 - 1975
  • [37] Clinical Outcomes of Melanoma Leptomeningeal Disease Treated with Intrathecal Chemotherapy, Immunotherapy, BRAF-targeted Therapy, or Radiation Therapy
    Mills, Matthew
    Li, Pinxue
    Liveringhouse, Casey
    Pina, Yolanda
    Yu, Hsiang-Hsuan
    Oliver, Daniel
    Vogelbaum, Michael
    Khushalani, Nikhil
    Forsyth, Peter
    Ahmed, Kamran
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S37 - S37
  • [38] Integrative analysis of resistance to BRAF-targeted therapies in lung adenocarcinomas
    Ortiz-Cuaran, Sandra
    Mazieres, Julien
    Swalduz, Aurelie
    Flores, Washington Rene Chumbi
    Loriot, Yohan
    Westeel, Virginie
    Pradines, Anne
    Tissot, Claire
    Duchene, Christelle Clement
    Raynaud, Christine
    Quantin, Xavier
    Gervais, Radj
    Brain, Etienne
    Monnet, Isabelle
    Leprieur, Etienne Giroux
    Neymarc, Severine
    Avrillon, Virginie
    Marteau, Solene
    Martinez, Severine
    Clapisson, Gilles
    Girerd-Chambaz, Nathalie
    Mahier, Celine
    Hoog-Labouret, Nathalie
    de Kievit, Frank
    Howarth, Karen
    Green, Emma
    Morris, Clive
    Perol, Maurice
    Blay, Jean-Yves
    Saintingy, Pierre
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [39] Successful (neo)adjuvant BRAF-targeted therapy in a patient with locally advanced BRAF V600E mutant melanoma
    Seremet, Teofila
    Lienard, Danielle
    Suppa, Mariano
    Trepant, Anne-Laure
    Rorive, Sandrine
    Woff, Erwin
    Cuylits, Nicolas
    Jansen, Yanina
    Schreuer, Max
    del Marmol, Veronique
    Neyns, Bart
    [J]. MELANOMA RESEARCH, 2015, 25 (02) : 180 - 183
  • [40] Disrupting ATF4 Expression Mechanisms Provides an Effective Strategy for BRAF-Targeted Melanoma Therapy
    Nagasawa, Ikuko
    Koido, Masaru
    Tani, Yuri
    Tsukahara, Satomi
    Kunimasa, Kazuhiro
    Tomida, Akihiro
    [J]. ISCIENCE, 2020, 23 (04)
12345